• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Indian Physiatry Platform Spry Plans US Entry with Latest $3M Seed Funding

Share:

December 18, 2021

Physiatry platform developer Spry has snapped up $3 million in seed funding, a round led by India-focused venture capital fund Together Fund.

The investing bout also drew participation from FJ Labs, Pareto, Knowledge Capital, AngelList, and Whiteboard Capital.

WHAT IT DOES

Founded in March this year, the startup offers a full-stack digital platform in the movement health space, which includes physiatry or physical medicine and rehabilitation and physical therapy.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Its cloud-based system assists physical therapy practitioners and business owners in managing their clinical and administrative functions. Spry, according to a news report, supports all clinical functions from scheduling to patient intake and communication, assessments, EMR, home exercise plans, adherence tracking, and patient lifecycle management.

WHAT IT’S FOR

Spry will deploy its new funds to start crafting a go-to-market strategy in the United States. The startup also aims to expand locally in India, as well as boost product development.

MARKET SNAPSHOT

More digital physical therapy players have attracted investors’ money this year. In September,

RecoveryOne collected $33 million in Series C funding. Rival Hinge Health in October scored $400 million in a Series E funding round, plus $200 million in secondary investment from Alkeon and Whale Rock. The following month, another competitor SWORD Health also raised $163 million in Series D funding, which was also oversubscribed for $26 million.

ON THE RECORD

“Through Spry, we aim to democratise access to movement health and help people incorporate it into their daily routines rather than opting for it as a quick-fix solution,” Spry co-founder and CEO Brijraj Bhuptani was quoted as saying.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • RadioMedix Inc. Announces the Acquisition of Its 225Ac-PSMA I&T Program, a Targeted Alpha Therapy (TAT) for Metastatic Castration-resistant Prostate Cancer, By Fusion Pharmaceuticals Inc.RadioMedix Inc. Announces the Acquisition of Its 225Ac-PSMA I&T Program, a Targeted Alpha Therapy (TAT) for Metastatic Castration-resistant Prostate Cancer, By Fusion Pharmaceuticals Inc.
  • Olive Lands $51M to Power AI-powered Digital Employee PlatformOlive Lands $51M to Power AI-powered Digital Employee Platform
  • The Patient Journey Tech Stack: 10 Pharma Predictions for 2023The Patient Journey Tech Stack: 10 Pharma Predictions for 2023
  • Sprout Launches with $10M to Power Tech-Enabled In-Home Autism CareSprout Launches with $10M to Power Tech-Enabled In-Home Autism Care
  • Practice Management Software Tebra Secures $72MPractice Management Software Tebra Secures $72M
  • Eko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac ExamEko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
  • Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19
  • German Research University Pitches Telemedicine as An Emergency Medical ToolGerman Research University Pitches Telemedicine as An Emergency Medical Tool

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications